SC 13G Filing

Company

Moleculin Biotech, Inc.

Filed

April 8, 2019

Accession Number

0000919574-19-002792

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →